View Single Post
Old 11-18-2011, 09:32 AM   #5
AlaskaAngel
Senior Member
 
AlaskaAngel's Avatar
 
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
Question Re: another example of needing to find the right subgroup to determine drugs efficacy

What it reminds me of that is quite specific to HER2 positive is the most obvious subgroup that still is waiting to be identified.... since the homework has never been done to find out if the group of early stage HER2 positive breast cancer has a BETTER outcome with trastuzumab used alone than with chemotherapy. At present this possibility continues to be just written off entirely.

Just think of how beneficial this could be in terms of people and resources if it ever saw the light of day.

AlaskaAngel
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
AlaskaAngel is offline   Reply With Quote